Eva-Doreen Pfister
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eva-Doreen Pfister has a total of 226 co-authors. Here are the top co-authors by number of shared publications:
- Ulrich Baumann
Division of Pediatric Gastroenterology and Hepatology, Department of Pediatric Kidney, Liver, Metabolic, and Neurological Diseases, Hannover Medical School, Hannover, Germany
19 shared publications Ulrich Baumann
Hannover Medical School, Clinic for Pediatric Kidney, Liver, and Metabolic Diseases and Neuropediatrics Hannover Germany
10 shared publications- Johanna Ohlendorf
Pediatric Gastroenterology, Hepatology and Liver Transplantation, Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School, 30625 Hannover, Germany
8 shared publications - Amelie Stalke
Department of Human Genetics, Hannover Medical School, Hannover, Germany
6 shared publications - Imeke Goldschmidt
Division of Pediatric Hepatology and Liver Transplantation, Department of Pediatric Liver, Kidney and Metabolic Diseases and Neuropediatrics, Hannover Medical School, Hannover, Germany
6 shared publications - Norman Junge
Division for Pediatric Gastroenterology and Hepatology, Department of Pediatric Kidney, Liver, and Metabolic Diseases Hannover Medical School Hannover Germany
6 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (10) , e70501
Early Morbidity and Survival After Left Lateral Segment Versus Whole Liver Graft Transplantation in Children
Background: Left lateral segment (LLS) grafts expand graft availability for infants and small children requiring liver transplantation (LT). However, their cumulative early postoperative burden compared with whole liver grafts (WLGs) remains incompletely characterized. Methods: This retrospective single‐center cohort study included 95 consecutive primary pediatric LT recipients treated between 2019 and 2024, comprising 56 LLS and 39 WLG recipients. Cumulative postoperative morbidity within 90 days was quantified using the Comprehensive Complication Index (CCI). Additional outcomes included biliary and vascular complications, unplanned surgical reinterventions, length of stay, graft loss, retransplantation, and graft and patient survival. Results: LLS recipients were younger and smaller than WLG recipients. Cumulative 90‐day morbidity was greater after LLS transplantation (median CCI 53 vs. 45, p = 0.002). LLS recipients had higher rates of bile leakage (18% vs. 3%, p = 0.024), intra‐abdominal bleeding (15% vs. 0%, p = 0.019), and unplanned surgical reintervention (43% vs. 8%, p < 0.001). Although the overall incidence of biliary complications was similar between groups, anastomotic biliary strictures during follow‐up were more frequent after WLG transplantation (28% vs. 9%, p = 0.014). Hospital stay was longer after LLS transplantation (median 43 vs. 27 days, p < 0.001). No statistically significant differences in graft loss, retransplantation, or graft and patient survival were detected between groups. Conclusions: LLS transplantation was associated with greater cumulative morbidity within 90 days, characterized by higher rates of bile leakage, intra‐abdominal bleeding, unplanned surgical reintervention, and prolonged hospitalization. Despite this greater early postoperative burden, no statistically significant differences in graft loss, retransplantation, or graft and patient survival were detected during the available follow‐up. These findings support continued use of LLS grafts to expand transplant access. Given the associated early morbidity, it highlights the importance of an experienced surgical and medical team.
- 20 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (10) , e70501
Open AccessEarly Morbidity and Survival After Left Lateral Segment Versus Whole Liver Graft Transplantation in Children
Background: Left lateral segment (LLS) grafts expand graft availability for infants and small children requiring liver transplantation (LT). However, their cumulative early postoperative burden compared with whole liver grafts (WLGs) remains incompletely characterized. Methods: This retrospective single‐center cohort study included 95 consecutive primary pediatric LT recipients treated between 2019 and 2024, comprising 56 LLS and 39 WLG recipients. Cumulative postoperative morbidity within 90 days was quantified using the Comprehensive Complication Index (CCI). Additional outcomes included biliary and vascular complications, unplanned surgical reinterventions, length of stay, graft loss, retransplantation, and graft and patient survival. Results: LLS recipients were younger and smaller than WLG recipients. Cumulative 90‐day morbidity was greater after LLS transplantation (median CCI 53 vs. 45, p = 0.002). LLS recipients had higher rates of bile leakage (18% vs. 3%, p = 0.024), intra‐abdominal bleeding (15% vs. 0%, p = 0.019), and unplanned surgical reintervention (43% vs. 8%, p < 0.001). Although the overall incidence of biliary complications was similar between groups, anastomotic biliary strictures during follow‐up were more frequent after WLG transplantation (28% vs. 9%, p = 0.014). Hospital stay was longer after LLS transplantation (median 43 vs. 27 days, p < 0.001). No statistically significant differences in graft loss, retransplantation, or graft and patient survival were detected between groups. Conclusions: LLS transplantation was associated with greater cumulative morbidity within 90 days, characterized by higher rates of bile leakage, intra‐abdominal bleeding, unplanned surgical reintervention, and prolonged hospitalization. Despite this greater early postoperative burden, no statistically significant differences in graft loss, retransplantation, or graft and patient survival were detected during the available follow‐up. These findings support continued use of LLS grafts to expand transplant access. Given the associated early morbidity, it highlights the importance of an experienced surgical and medical team.
- Open Access
- 22 September 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (10) , e2013
Thirty Years and Beyond: Long-term Outcomes After Liver Transplantation at a Single Center: Progress, Challenges, and Future Implications
Background.: The liver transplantation (LT) program was established at Hannover Medical School in 1972. The aim of the study was to assess graft and patient survival, organ function, and active life throughout ≥3 decades after LT, with a special focus on recipients surviving ≥30 y after transplantation. Methods.: Clinical data from all consecutive patients undergoing LT between 1972 and 1994 were collected in a prospective design, and outcome data were complemented retrospectively. Results.: Nine hundred LTs performed on 756 patients were included in the study. Survival increased with growing experience during the study period. One hundred thirty-eight patients survived ≥30 y, of whom 35 (25%) received >1 graft. Chronic kidney disease was observed in 96 recipients (70%), necessitating additional kidney transplants in 16 patients (12%). De novo malignancy was diagnosed in 31 patients (23%; 4% after pediatric and 33% after adult LT, P < 0.001) during the long-term follow-up. The leading cause of death beyond a 30-y survival was cardiovascular. Twenty-seven patients (38%) had a child after LT; 33 pediatric transplant recipients (89%) engaged in professional employment posttransplant. Conclusions.: This is the first study offering detailed insight into LT survival beyond 30 y. The data show that 30-y survival after LT is reachable in relevant numbers, with stable graft function and the opportunity to live an active, self-directed life.
- 22 September 2026
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 12 (10) , e2013
Open AccessThirty Years and Beyond: Long-term Outcomes After Liver Transplantation at a Single Center: Progress, Challenges, and Future Implications
Background.: The liver transplantation (LT) program was established at Hannover Medical School in 1972. The aim of the study was to assess graft and patient survival, organ function, and active life throughout ≥3 decades after LT, with a special focus on recipients surviving ≥30 y after transplantation. Methods.: Clinical data from all consecutive patients undergoing LT between 1972 and 1994 were collected in a prospective design, and outcome data were complemented retrospectively. Results.: Nine hundred LTs performed on 756 patients were included in the study. Survival increased with growing experience during the study period. One hundred thirty-eight patients survived ≥30 y, of whom 35 (25%) received >1 graft. Chronic kidney disease was observed in 96 recipients (70%), necessitating additional kidney transplants in 16 patients (12%). De novo malignancy was diagnosed in 31 patients (23%; 4% after pediatric and 33% after adult LT, P < 0.001) during the long-term follow-up. The leading cause of death beyond a 30-y survival was cardiovascular. Twenty-seven patients (38%) had a child after LT; 33 pediatric transplant recipients (89%) engaged in professional employment posttransplant. Conclusions.: This is the first study offering detailed insight into LT survival beyond 30 y. The data show that 30-y survival after LT is reachable in relevant numbers, with stable graft function and the opportunity to live an active, self-directed life.
- Open Access
- 8 September 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (9)
Left Lateral Segment Liver Transplantation in Small Infants: Outcomes From a High‐Volume Center
Background: Graft selection in small infants is challenging due to size mismatch and the associated risk of vascular or biliary complications. Methods: In this retrospective single‐center study, 57 pediatric liver transplants using left lateral segment grafts performed between 2019 and 2024 were analyzed and compared by recipient weight (< 10 kg vs. ≥ 10 kg). Results: Overall graft survival was 88% in the < 10 kg group and 96% in the ≥ 10 kg group. Patient survival at 1, 2, and 4 years was similar between groups ( p = 0.500). The graft‐to‐recipient weight ratio was significantly higher in smaller recipients (4.64% vs. 2.37%, p < 0.05), and hepatic artery thrombosis occurred only in this group (9%). Biliary complications were comparable between cohorts (27% vs. 30%). Acute cellular rejection (57% vs. 12%, p < 0.001) and 90‐day readmissions (57% vs. 27%, p = 0.022) were significantly more common in children weighing ≥ 10 kg. Conclusion: In this selected cohort, left lateral segment transplantation was associated with excellent outcomes across weight groups. Acceptable results in small infants were achieved despite higher GRWR in a specialized setting, supporting LLS grafts as an important option to improve access to timely pediatric transplantation.
- 8 September 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (9)
Open AccessLeft Lateral Segment Liver Transplantation in Small Infants: Outcomes From a High‐Volume Center
Background: Graft selection in small infants is challenging due to size mismatch and the associated risk of vascular or biliary complications. Methods: In this retrospective single‐center study, 57 pediatric liver transplants using left lateral segment grafts performed between 2019 and 2024 were analyzed and compared by recipient weight (< 10 kg vs. ≥ 10 kg). Results: Overall graft survival was 88% in the < 10 kg group and 96% in the ≥ 10 kg group. Patient survival at 1, 2, and 4 years was similar between groups ( p = 0.500). The graft‐to‐recipient weight ratio was significantly higher in smaller recipients (4.64% vs. 2.37%, p < 0.05), and hepatic artery thrombosis occurred only in this group (9%). Biliary complications were comparable between cohorts (27% vs. 30%). Acute cellular rejection (57% vs. 12%, p < 0.001) and 90‐day readmissions (57% vs. 27%, p = 0.022) were significantly more common in children weighing ≥ 10 kg. Conclusion: In this selected cohort, left lateral segment transplantation was associated with excellent outcomes across weight groups. Acceptable results in small infants were achieved despite higher GRWR in a specialized setting, supporting LLS grafts as an important option to improve access to timely pediatric transplantation.
- 14 November 2025
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 174 (1) , 16-24
Lebertransplantation bei Kindern und Jugendlichen
- 14 November 2025
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 174 (1) , 16-24
Lebertransplantation bei Kindern und Jugendlichen
- Open Access
- 29 September 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (11) , 110769
A farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis
- 29 September 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (11) , 110769
Open AccessA farnesoid X receptor T296I variant disrupts ligand-induced FXR activation and thus bile acid transport in progressive familial intrahepatic cholestasis
- Open Access
- 29 September 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (10)
iPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis
Background: Hereditary intrahepatic cholestasis is caused by variants of various genes involved in enterohepatic bile circulation, metabolization, and conjugation. Originally classified into 3 groups, the number of contributing genes is still increasing, underlining the need for a deeper understanding of the molecular interaction during intrahepatic cholestasis. Methods: In the present study, we investigate the interplay of heterozygous variants in 3 cholestasis-associated genes (ABCB11, ABCB4, and MYO5B) by exploiting iPSC-based hepatic organoids from a patient suffering from recurrent intrahepatic cholestasis. Results: Functional characterization of MRP2-mediated cholyl-lysyl-fluorescein (CLF) and BSEP-mediated Tauro-nor-THCA-24-DBD transport demonstrated a marked reduction of transport in MYO5B-deficient organoids, in comparison to unaffected control organoids. Moreover, iPSC-based organoids derived from the patient carrying 3 heterozygous variants in ABCB11, ABCB4, and MYO5B also exhibited absence of BSEP-mediated Tauro-nor-THCA-24-DBD transport, but functional MRP2-mediated CLF-transport. Interestingly, CRISPR/Cas9-mediated correction of the mutated ABCB11 allele could not restore the impaired BSEP function, suggesting the heterozygous MYO5B variant as the main driver of the transport deficiency. In fact, CRISPR/Cas-mediated correction of the MYO5B variant finally resulted in a restoration of the BSEP-mediated Tauro-nor-THCA-24-DBD transport. Conclusions: iPSC-based organoids serve as an authentic model for functional assessment of the hepatobiliary transport with fluorescent substrates. This allows the characterization of variants of uncertain significance and other variants in cholestasis-associated genes and revealed that a heterozygous MYO5B variant increases the susceptibility to defective hepatobiliary BSEP-mediated transport.
- 29 September 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (10)
Open AccessiPSC-based hepatic organoids reveal a heterozygous MYO5B variant as driver of intrahepatic cholestasis
Background: Hereditary intrahepatic cholestasis is caused by variants of various genes involved in enterohepatic bile circulation, metabolization, and conjugation. Originally classified into 3 groups, the number of contributing genes is still increasing, underlining the need for a deeper understanding of the molecular interaction during intrahepatic cholestasis. Methods: In the present study, we investigate the interplay of heterozygous variants in 3 cholestasis-associated genes (ABCB11, ABCB4, and MYO5B) by exploiting iPSC-based hepatic organoids from a patient suffering from recurrent intrahepatic cholestasis. Results: Functional characterization of MRP2-mediated cholyl-lysyl-fluorescein (CLF) and BSEP-mediated Tauro-nor-THCA-24-DBD transport demonstrated a marked reduction of transport in MYO5B-deficient organoids, in comparison to unaffected control organoids. Moreover, iPSC-based organoids derived from the patient carrying 3 heterozygous variants in ABCB11, ABCB4, and MYO5B also exhibited absence of BSEP-mediated Tauro-nor-THCA-24-DBD transport, but functional MRP2-mediated CLF-transport. Interestingly, CRISPR/Cas9-mediated correction of the mutated ABCB11 allele could not restore the impaired BSEP function, suggesting the heterozygous MYO5B variant as the main driver of the transport deficiency. In fact, CRISPR/Cas-mediated correction of the MYO5B variant finally resulted in a restoration of the BSEP-mediated Tauro-nor-THCA-24-DBD transport. Conclusions: iPSC-based organoids serve as an authentic model for functional assessment of the hepatobiliary transport with fluorescent substrates. This allows the characterization of variants of uncertain significance and other variants in cholestasis-associated genes and revealed that a heterozygous MYO5B variant increases the susceptibility to defective hepatobiliary BSEP-mediated transport.
- Open Access
- 1 January 2025
- Published by XMLink in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 28 (2) , 113-123
Clinical Outcomes of Percutaneous Transhepatic Biliary Drainage in Pediatric Patients following Liver Transplantation
Pape T, et al. Pediatr Gastroenterol Hepatol Nutr. 2025 Mar;28(2):113-123. https://doi.org/10.5223/pghn.2025.28.2.113
- 1 January 2025
- Published by XMLink in Pediatric Gastroenterology, Hepatology & Nutrition
- Vol. 28 (2) , 113-123
Open AccessClinical Outcomes of Percutaneous Transhepatic Biliary Drainage in Pediatric Patients following Liver Transplantation
Pape T, et al. Pediatr Gastroenterol Hepatol Nutr. 2025 Mar;28(2):113-123. https://doi.org/10.5223/pghn.2025.28.2.113
- 4 September 2024
- Published by Springer Nature
- p. 219-238
Lebertumore, Leberversagen und Lebertransplantation
- 4 September 2024
- Published by Springer Nature
- p. 219-238
Lebertumore, Leberversagen und Lebertransplantation
- 4 September 2024
- Published by Springer Nature
- p. 167-184
Cholestase
- 8 December 2023
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 172 (2) , 150-153
Handlungsempfehlung nach der S2k-Leitlinie „Cholestase im Neugeborenenalter“
- 8 December 2023
- Published by Springer Nature in Monatsschrift Kinderheilkunde
- Vol. 172 (2) , 150-153
Handlungsempfehlung nach der S2k-Leitlinie „Cholestase im Neugeborenenalter“